Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is abnormal male-pattern hair growth in females due to excess androgens.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

A new method accurately measures DHEAS in blood, improving on current tests.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

Isolated pubic hair in infants is usually harmless and resolves on its own.

Hirsutism in women can be a cosmetic issue or a sign of hormonal imbalance, treatable with hormonal and cosmetic methods.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Hirsutism and androgenetic alopecia in women are often due to increased androgen effects, and antiandrogen treatment is recommended to prevent further issues.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Multiple treatments work best for hair loss.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Eating dairy and high glycemic foods may increase the risk of acne.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Androgens and other hormones affect hair growth and skin conditions like acne.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Review finds no permanent solution for female hair loss.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.